View all services

30 August 2016 • Articles

The Wall Street Journal, US

Morrow Sodali advisor on the Pfizer - Medivation acquisition

Morrow Sodali will act as Information Agent in the Pfizer - Medivation M&A deal.

The Companies have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion.


For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.